Browse Companies
Discover companies hiring across Latin America
Loading companies...
Discover companies hiring across Latin America
Showing 1 to 3 of 3 companies
AstraZeneca is a global pharmaceutical company focused on the research, development, and commercialization of prescription medicines. With around 90,000 employees in 85 countries, the company aims to harness scientific advancements for the benefit of people and society. AstraZeneca operates in various functions, including Clinical Development, Regulatory Affairs, Finance, IT, and Manufacturing. The company specializes in three main therapeutic areas: oncology, respiratory, and immunology. In oncology, AstraZeneca is dedicated to developing innovative treatments that aim to redefine cancer care. In the respiratory and immunology sectors, the company works to improve outcomes for patients with asthma and COPD, as well as other immune-driven diseases. Additionally, AstraZeneca has expanded its focus on rare diseases through its acquisition of Alexion, enhancing its capabilities in this area. The company is committed to advancing science and creating impactful therapies across multiple health conditions.
GSK plc (GlaxoSmithKline) is a global biopharmaceutical company dedicated to developing vaccines and specialty medicines. With a history dating back to 1715, it is recognized as the longest continually running British pharmaceutical company. GSK has evolved through numerous mergers and innovations, employing around 70,000 people worldwide. The company focuses on areas such as oncology, respiratory diseases, HIV, and infectious diseases. GSK has a strong legacy in research and development, with significant contributions to antibiotics and treatments for various health conditions. Following a demerger in 2022, GSK has streamlined its operations to concentrate on biopharma research and development, enhancing its capabilities through strategic acquisitions.
Syneos Health is a fully integrated biopharmaceutical solutions organization formed in 2018 through the merger of INC Research and InVentiv Health. With over 26,000 employees across more than 110 countries, the company focuses on synchronizing clinical development and commercial execution for biopharmaceutical clients. Syneos Health leverages AI and technology to enhance customer success, translating insights into outcomes while addressing the challenges of product lifecycles from preclinical stages to market launch. The company offers comprehensive biopharmaceutical solutions that include clinical development, commercialization, and consulting services. Its expertise spans various therapeutic areas, including oncology, central nervous system, and immunology. Syneos Health Consulting provides advisory services across the drug development lifecycle, supporting portfolio strategy, medical affairs, and risk management. The firm has played a significant role in the development and commercialization of a high percentage of novel drugs, contributing to the approval of numerous FDA and EMA products.